20240227_MEDS_Pemanggilan RUPS_31581090_lamp2.pdf

B. Rapat Umum Pemegang Saham Luar Biasa
   1. Persetujuan Atas Perubahan Susunan Pengurus Perseroan
       Penjelasan:
       Persetujuan Perubahan Susunan Pengurus Perseroan guna memperkuat struktur organisasi Perseroan.

Catatan:
1.    Rapat akan diselenggarakan dengan mengacu pada Peraturan Otoritas Jasa Keuangan Nomor 15/POJK.04/2020 tentang
      Rencana dan Penyelenggaraan Rapat Umum Pemegang Saham Perusahaan Terbuka dan Peraturan Otoritas Jasa Keuangan
      Nomor 16/POJK.04/2020 tentang Pelaksanaan Rapat Umum Pemegang Saham Perusahaan Terbuka secara Elektronik.
2.    Perseroan tidak mengirimkan undangan tersendiri kepada masing-masing Pemegang saham Perseroan, sehingga
      Pemanggilan ini merupakan undangan resmi bagi seluruh Pemegang Saham Perseroan. Pemanggilan ini dapat
      dilihat juga pada situs web Perseroan (https://www.evoplusmed.com), aplikasi penyelenggaraan RUPS secara
      elektronik atau (“eASY.KSEI”) yang disediakan oleh PT Kustodian Sentral Efek Indonesia (“KSEI”) yang dapat
      diakses melalui situs web KSEI (https://akses.ksei.co.id), dan situs web PT Bursa Efek Indonesia (“BEI”).
3.    Pemegang saham yang berhak hadir atau diwakili dalam Rapat adalah para Pemegang Saham Perseroan yang
      namanya tercatat dalam Daftar Pemegang Saham Perseroan pada penutupan jam perdangangan Bursa Efek
      tanggal 05 Maret 2024 pukul 16.00 WIB
4.    Keikutsertaan Pemengang Saham dalam Rapat, dapat dilakukan dengan mekanisme sebagai berikut:
      a. Hadir dalam Rapat secara fisik; atau
      b. Hadir dalam Rapat secara elektronik melalui aplikasi eASY.KSEI.
5.    Pemegang Saham yang tidak dapat hadir dalam Rapat dapat diwakilkan oleh pihak independen yang telah ditunjuk oleh
      Perseroan yaitu perwakilan dari PT Sinartama Gunita selaku Biro Administrasi Efek (“BAE”), dengan memberikan
      kuasa secara konvensional menggunakan format surat kuasa tertulis yang dapat diunduh pada situs web
      Perseroan (https://www.evoplusmed.com). Surat Kuasa wajib diisi dan diserahkan kepada BAE paling lambat 1
      (satu) hari kerja sebelum tanggal penyelenggaraan Rapat yang beralamat di Menara Tekno Lantai 7 Jl. H. Fachrudin
      No.19 Tanah Abang, Jakarta Pusat.
6.    Pemegang Saham atau Kuasanya yang sah, yang akan menghadiri Rapat secara fisik diminta dengan hormat untuk
      menyerahkan fotokopi Kartu Tanda Penduduk (“KTP”) kepada petugas Rapat, dan wajib membawa Konfirmasi Tertulis Untuk
      Rapat (“KTUR”) yang dapat diperoleh dari Perusahaan Efek atau Bank Kustodian dimana Pemegang Saham membuka
      rekening efeknya.
7.    Bagi Pemegang Saham yang berbentuk badan hukum seperti Perseroan Terbatas, Koperasi, Yayasan, atau Dana Pensiun wajib
      membawa fotokopi anggaran dasar yang terbaru dan lengkap, serta pengesahan atas akta pendirian dan persetujuan atas
      perubahan anggaran dasar yang terakhir dari Departemen Hukum dan Hak Asasi Manusia Republik Indonesia berikut susunan
      pengurus yang terakhir.
8.    Untuk menjamin kelancaran dan tertibnya Rapat, Pemegang Saham atau Kuasanya yang sah diminta dengan hormat untuk
      hadir ditempat Rapat 30 (tiga puluh ) menit sebelum Rapat dimulai.
9.    Bahan-bahan Rapat dan Tata tertib pelaksanaan Rapat dapat diakses melalui situs web Perseroan sejak tanggal panggilan ini.
10. Perseroan menghimbau para pemegang saham Perseroan untuk terlebih dahulu membaca Tata Tertib Rapat
      termasuk panduan pelaksanaan Rapat secara elektronik bagi yang akan hadir secara elektronik yang tersedia di
      aplikasi eASY.KSEI. Dengan telah disampaikannya tata tertib tersebut, maka Pemegang Saham atau Kuasanya yang sah
      dianggap telah memahami dan akan mentaati selama pelaksanaan Rapat berlangsung.




                                                   Cimahi, 06 Maret 2024
                                             PT HETZER MEDICAL INDONESIA TBK
                                                      Direksi Perseroan

                                                           INVITATION
                                                       TO SHAREHOLDERS
                                                PT HETZER MEDICAL INDONESIA Tbk



The Board of Directors of PT Hetzer Medical Indonesia Tbk (the “Company”) hereby invites the shareholders of the
Company to attend the Annual and Extraordinary General Meeting of Shareholders (the “Meeting”), which will be held
on:
    Day/Date                          : Thursday, March 28, 2024
    Time                              : 10.00 am Western Indonesia Time until the finish
    Venue                             : Company Office
                                         Kompleks Blue Sky Industrial Kav. 09, Jl. Nanjung No. 02
                                         Kelurahan Leuwigajah, Kecamatan Cimahi Selatan, Kota Cimahi.

The agenda items that will be proposed at the Meeting to be discussed and obtain decisions from the Company's
shareholders are as follows:

A. Annual General Meeting of Shareholders
   1. Approval of the Company's Annual Report regarding the condition and operations of the Company during the 2023 Financial
      Year including the Report on the Implementation of the Board of Commissioners' Supervisory Duties during the 2023 Financial
      Year, and Ratification of the Company's Financial Report for the 2023 Financial Year as well as granting full release and discharge
      of responsibility (acquit et de charge) to the Board of Directors and the Company's Board of Commissioners for the
      management and supervision that has been carried out during the 2023 Financial Year.
      Explanation :
      Based on Article 66 of Law Number 40 of 2007 concerning Limited Liability Companies (UUPT), where the Annual Report,
      Financial Report, and Report on Management and Supervision Tasks must be sought for approval and ratification at the Annual
      General Meeting of Shareholders.

   2. Determination of the Company's Net Profit Use Plan for the 2023 Financial Year
      Explanation :
      Based on articles 70 and 71 paragraph 1 of the Company Law, the use of the Company's net profit, including determining the
      amount of allowance for reserves, is decided by the Annual General Meeting of Shareholders.

   3. Appointment of a Public Accountant for the Financial Year ending December 31, 2024
      Explanation :
      Based on Article 13 of the Financial Services Authority Regulation Number 13/POJK.03/2017 concerning the Use of Public
      Accountant Services and Public Accounting Firms in Financial Services Activities, it is stated that the appointment of Public
      Accountants and/or Public Accounting Firms will provide audit services for annual historical financial information. must be
      decided at the GMS by considering the Board of Commissioners' proposals. In the event that the GMS cannot decide on the
      appointment of a Public Accountant and/or Public Accounting Firm, the GMS can delegate the authority to appoint to the
      Board of Commissioners.

   4. Determination of the Honorarium for Members of the Company's Board of Commissioners and Directors
      Explanation :
      Following Article 96 in conjunction with Article 113 of the Company Law, the honorarium and other allowances for members
      of the Company's Board of Directors and Board of Commissioners are determined by the GMS.

   5. Approval of the Realization Report on the Use of Proceeds from the Initial Public Offering of Shares
      Explanation :
      Based on Article 6 paragraphs (1) and (2) POJK Number 30/POJK.04/2015 concerning Report on the Realization of Use of Funds
      from Public Offerings, the Company as a Public Company is obliged to account for the realization of the use of funds from Public
      Offerings at each Annual GMS up to all proceeds. The Public Offering has been realized and must be included as one of the
      agenda items at the Annual GMS.

B. Extraordinary General Meeting of Shareholders
    1. Approval of Changes to the Composition of the Company's Management
        Explanation :
        Approval of Changes to the Composition of the Company's Management in connection with the resignation of the
        Company's Board of Commissioners and President Director, to strengthen the Company's organizational structure.

Notes:
1.     The meeting will be held concerning Financial Services Authority Regulation Number 15/POJK.04/2020 concerning Planning
       and Organizing General Meetings of Shareholders of Public Companies and Financial Services Authority Regulation Number
       16/POJK.04/2020 concerning Implementation of General Meetings of Shareholders of Companies Open Electronically.
2.     The Company does not send a separate invitation to each shareholder of the Company, so this invitation is an official invitation
       for all Shareholders of the Company. This summons can also be seen on the Company's website
       (https://www.evoplusmed.com), the electronic GMS holding application ("eASY.KSEI") provided by PT Kustodian Sentral Efek
       Indonesia ("KSEI") which can be accessed via the KSEI website (https://akses.ksei.co.id), and the PT Bursa Efek Indonesia (“BEI”)
       website.
3.     Shareholders who have the right to attend or be represented at the Meeting are the Company's Shareholders whose names
       are registered in the Company's Register of Shareholders at the close of Stock Exchange trading hours on 05 March 2024 at
       16.00 WIB.
4.     Shareholder participation in the Meeting can be carried out using the following mechanism:
       a.      Be physically present at the meeting; or
       b.      Attend the Meeting electronically via the eASY.KSEI application.
5.     Shareholders who are unable to attend the Meeting can be represented by an independent party appointed by the Company,
       namely a representative from PT Sinartama Gunita as the Securities Administration Bureau ("BAE"), by providing conventional
       power of attorney using a written power of attorney format which can be downloaded at the Company website
       (https://www.evoplusmed.com). The Power of Attorney must be filled out and submitted to BAE no later than 1 (one) working
       day before the date of the Meeting which is located at Menara Tekno Floor 7 Jl. H. Fachrudin No.19 Tanah Abang, Central
       Jakarta.
6.     Shareholders or their legal proxies, who will physically attend the Meeting are kindly requested to submit a photocopy of their
       Resident Identification Card (“KTP”) to the meeting officer and are required to bring Written Confirmation for the Meeting
       (“KTUR”) which can be obtained from Securities Company or Custodian Bank where Shareholders open their securities
       accounts.
7.     Shareholders in the form of legal entities such as Limited Liability Companies, Cooperatives, Foundations, or Pension Funds are
       required to bring a photocopy of the most recent and complete articles of association, as well as ratification of the deed of
       establishment and approval of the latest amendments to the articles of association from the Department of Law and Human
       Rights. Republic of Indonesia following the latest management structure.
8.     To ensure the smooth and orderly running of the Meeting, Shareholders or their legal proxies are kindly requested to be
       present at the Meeting venue 30 (thirty) minutes before the Meeting starts.
9.     Meeting materials and Meeting Rules and Regulations can be accessed via the Company's website from the date of this
       summons.
10. The Company urges the Company's shareholders to first read the Meeting Rules of Conduct including the guidelines for
       conducting electronic Meetings for those who will attend electronically which are available on the eASY.KSEI application. By
       submitting these rules and regulations, the Shareholders or their legal proxies are deemed to have understood and will comply
       during the Meeting.




                                                     Cimahi, March 06, 2024
                                               PT HETZER MEDICAL INDONESIA TBK
                                               Board of Directors of the Company